Treatment of tumors with rar alpha selective retinoid...

C - Chemistry – Metallurgy – 07 – C

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07C 235/66 (2006.01) A61K 31/196 (2006.01) A61K 31/245 (2006.01) A61K 38/21 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2405136

Compounds which are specific or selective agonists of RAR.alpha. receptors in preference over RAR.beta. and RAR.gamma. recep-tors, and particularly compounds of the formula (I) where R is a H, lower alkyl of 1 to 6 carbons, or a pharmaceutically acceptable salt, are useful for treating a malignant disease or condition in a mammal. In treatment of solid tumors the compound exhibit syn-ergistic antiproliferative effect with human recombinant interferon.

L'invention concerne des composés se présentant sous la forme d'agonistes spécifiques ou sélectifs des récepteurs RAR alpha , par préférence aux récepteurs RAR beta et RAR gamma , et notamment des composés de formule (I), dans laquelle R est H, alkyle inférieur de 1 à 6 atomes de carbone, ou un sel pharmaceutiquement acceptable. Ces composés sont utiles pour traiter une affection maligne chez un mammifère. Dans le traitement de tumeurs solides, lesdits composés présentent une activité anti-proliférative synergique avec un interféron recombinant humain.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Treatment of tumors with rar alpha selective retinoid... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of tumors with rar alpha selective retinoid..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of tumors with rar alpha selective retinoid... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1588755

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.